Abstract:BackgroundFibroblastic foci are characteristic features in lung parenchyma of patients with idiopathic pulmonary fibrosis (IPF). They comprise aggregates of mesenchymal cells which underlie sites of unresolved epithelial injury and are associated with progression of fibrosis. However, the cellular origins of these mesenchymal phenotypes remain unclear. We examined whether the potent fibrogenic cytokine TGF-β1 could induce epithelial mesenchymal transition (EMT) in the human alveolar epithelial cell line, A549, and investigated the signaling pathway of TGF-β1-mediated EMT.MethodsA549 cells were examined for evidence of EMT after treatment with TGF-β1. EMT was assessed by: morphology under phase-contrast microscopy; Western analysis of cell lysates for expression of mesenchymal phenotypic markers including fibronectin EDA (Fn-EDA), and expression of epithelial phenotypic markers including E-cadherin (E-cad). Markers of fibrogenesis, including collagens and connective tissue growth factor (CTGF) were also evaluated by measuring mRNA level using RT-PCR, and protein by immunofluorescence or Western blotting. Signaling pathways for EMT were characterized by Western analysis of cell lysates using monoclonal antibodies to detect phosphorylated Erk1/2 and Smad2 after TGF-β1 treatment in the presence or absence of MEK inhibitors. The role of Smad2 in TGF-β1-mediated EMT was investigated using siRNA.ResultsThe data showed that TGF-β1, but not TNF-α or IL-1β, induced A549 cells with an alveolar epithelial type II cell phenotype to undergo EMT in a time-and concentration-dependent manner. The process of EMT was accompanied by morphological alteration and expression of the fibroblast phenotypic markers Fn-EDA and vimentin, concomitant with a downregulation of the epithelial phenotype marker E-cad. Furthermore, cells that had undergone EMT showed enhanced expression of markers of fibrogenesis including collagens type I and III and CTGF. MMP-2 expression was also evidenced. TGF-β1-induced EMT occurred through phosphorylation of Smad2 and was inhibited by Smad2 gene silencing; MEK inhibitors failed to attenuate either EMT-associated Smad2 phosphorylation or the observed phenotypic changes.ConclusionOur study shows that TGF-β1 induces A549 alveolar epithelial cells to undergo EMT via Smad2 activation. Our data support the concept of EMT in lung epithelial cells, and suggest the need for further studies to investigate the phenomenon.

Effect of Hepatocyte Growth Factor on Transforming Growth Factor-Betal Triggered Epithelial-Myofibroblast Transdifferentiation of Alveolar Ⅱ Cells in Vitro

[Effects of Hepatocyte Growth Factor on TGF-beta1 Triggered Tubular Epithelial-Myofibroblast Transdifferentiation by CTGF in Vitro].

Cell-specific expression of human HGF by alveolar type II cells induces remodeling of septal wall tissue in the lung: a morphometric study

Effects of Hepatocyte Growth Factor and Angiotensin Ⅱ on Transdifferentiation of Tubular Epithelial-Myofibroblasts and Their Mechanisms

Effect of TGF-β1 and EGF on the Phenotypical Change and Function of Type Ⅱ Alveolar Epithelial Cells

[Effects of Hepatocyte Growth Factor on IL-1alpha Triggered Tubular Epithelial-Myofibroblast Transdifferentiation and Fibronectin Secretion in Vitro].

Effect of Hepatocyte Growth Factor on Human Renal Tubular Epithelial Cells Induced by High Glucose and Connective Tissue Growth Factor

Effects on TGF-β1-inducedα-SMA positive myofibroblasts by HGF

Targeted Gene Transfer of Hepatocyte Growth Factor to Alveolar Type II Epithelial Cells Reduces Lung Fibrosis in Rats.

Regulatory Mechanisms of TGF‐β1‐induced Fibrogenesis of Human Alveolar Epithelial Cells

Hepatocyte Growth Factor Regulates the TGF-β1-induced Proliferation, Differentiation and Secretory Function of Cardiac Fibroblasts.

TGF-β1 induces human alveolar epithelial to mesenchymal cell transition (EMT)

The Effect of TGF-β1 and Smad7 Gene Transfer on the Phenotypic Changes of Rat Alveolar Epithelial Cells

Gene Transfer of Hepatocyte Growth Factor by Electroporation Reduces Bleomycin-Induced Lung Fibrosis

Epithelial-mesenchymal Transition of Type Ⅱ Alveolar Epithelial Cells Induced by TGF-β1

[To Transdifferentiate Human Hypertrophic Scar Fibroblasts Induced by Connective Tissue Growth Factor Mediated Transforming Growth Factor-Beta 1 in Vitro].

Transforming Growth Factor-Β1-induced Epithelial-Mesenchymal Transition of Rat Type II Alveolar Epithelium and Pulmonary Fibrosis

Human alveolar epithelial cells type II are capable of TGFβ-dependent epithelial-mesenchymal-transition and collagen-synthesis

Therapeutic Effects of Conditioned Medium from Bone Marrow-Derived Mesenchymal Stem Cells on Epithelial-Mesenchymal Transition in A549 Cells.

Effect of Hepatic Carcinoma Ce1l Supernatant on Expressions of Α-Smooth Muscle Actin, Cyclooxygenase-2 and Hepatocyte Growth Factor in Fibroblasts

The Effect of Alveolar Typeiicell to Lung Fibroblast in the Rat Model of Pingyangmycin Induced Pulmonary Fibrosis